Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 13;5(2):97-99.
doi: 10.1515/almed-2024-0075. eCollection 2024 Jun.

Mass spectrometry in clinical protein laboratories

Affiliations

Mass spectrometry in clinical protein laboratories

Carmen Mugueta et al. Adv Lab Med. .
No abstract available

Keywords: mass spectrometry; monoclonal gammopathies; multiple myeloma.

PubMed Disclaimer

References

    1. Guan L, Su W, Zhong J, Qiu L. M-protein detection by mass spectrometry for minimal residual disease in multiple myeloma. Clin Chim Acta. 2024;552:117623. doi: 10.1016/j.cca.2023.117623. Epub 2023 Nov 2. - DOI - PubMed
    1. Murray DL. Bringing mass spectrometry into the care of patients with multiple myeloma. Int J Hematol. 2022;115:790–8. doi: 10.1007/s12185-022-03364-2. Epub 2022 Apr 26. - DOI - PubMed
    1. Puig N, Contreras MT, Agulló C, Martínez-López J, Oriol A, Blanchard MJ, et al. Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma. Blood Adv. 2022;6:3234–9. doi: 10.1182/bloodadvances.2021006762. - DOI - PMC - PubMed
    1. Murray SL, Puig N, Kristinsson S, Usmani SZ, Dispenzieri A, Bianchi G, et al. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an international myeloma working Group mass spectrometry committee report. Blood Cancer J. 2021;11:24. doi: 10.1038/s41408-021-00408-4. - DOI - PMC - PubMed

LinkOut - more resources